Select Medical Holdings Co. (NYSE:SEM) Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC grew its stake in Select Medical Holdings Co. (NYSE:SEMFree Report) by 2.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,442,321 shares of the health services provider’s stock after purchasing an additional 46,880 shares during the period. Geode Capital Management LLC owned approximately 1.89% of Select Medical worth $85,180,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC purchased a new position in Select Medical during the second quarter worth about $229,000. Louisiana State Employees Retirement System lifted its holdings in Select Medical by 2.9% in the second quarter. Louisiana State Employees Retirement System now owns 53,600 shares of the health services provider’s stock valued at $1,879,000 after acquiring an additional 1,500 shares during the last quarter. Argent Capital Management LLC grew its position in Select Medical by 53.7% in the second quarter. Argent Capital Management LLC now owns 23,915 shares of the health services provider’s stock worth $838,000 after acquiring an additional 8,358 shares during the period. Ceredex Value Advisors LLC acquired a new stake in Select Medical during the second quarter worth $11,456,000. Finally, Miller Howard Investments Inc. NY purchased a new stake in Select Medical in the second quarter valued at $659,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on SEM. Royal Bank of Canada increased their price target on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Tuesday, December 3rd. Finally, Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th.

Read Our Latest Research Report on Select Medical

Insider Buying and Selling

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now directly owns 22,000 shares in the company, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by corporate insiders.

Select Medical Stock Down 0.1 %

SEM stock opened at $18.26 on Friday. The company’s 50 day moving average is $30.08 and its two-hundred day moving average is $33.34. Select Medical Holdings Co. has a twelve month low of $18.02 and a twelve month high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a market cap of $2.36 billion, a P/E ratio of 8.53, a PEG ratio of 0.39 and a beta of 1.43.

Select Medical (NYSE:SEMGet Free Report) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.46 EPS. Research analysts expect that Select Medical Holdings Co. will post 1.97 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were issued a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 2.74%. The ex-dividend date was Wednesday, November 13th. Select Medical’s payout ratio is 23.36%.

About Select Medical

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEMFree Report).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.